Abstract:(Cell Stem Cell 4, 16–19; January 9, 2009) In our recent article, we unfortunately misquoted the findings in a recent study by Ying et al., 2008Ying Q.-L. Wray J. Nichols J. Batlle-Morera L. Doble B. Woodgett J. Cohen P. Smith A. The ground state of embryonic stem cell self-renewal.Nature. 2008; 453: 519-523Crossref PubMed Scopus (2530) Google Scholar. When describing previous work using combination of the MEK inhibitor PD0325901 and the GSK3b inhibitor CHIR99021, our statement “Recent studies demonstrated that addition of the FGFR inhibitor PD173074 to the above cocktail is sufficient to maintain mESC pluripotency in the absence of LIF (Ying et al., 2008Ying Q.-L. Wray J. Nichols J. Batlle-Morera L. Doble B. Woodgett J. Cohen P. Smith A. The ground state of embryonic stem cell self-renewal.Nature. 2008; 453: 519-523Crossref PubMed Scopus (2530) Google Scholar).” was not accurate. Ying et al., in fact, used PD0325901 to replace PD1730474 and demonstrated maintenance of mESCs in the absence of LIF with these two factors only. The corrected section reads “Indeed, after serial passages, the growth of putative riPSCs treated with only PD0325901 and CHIR99021 declined, and the culture deteriorated due to the expansion of differentiated cells, although recent studies demonstrated that this combination of inhibitors can be used to maintain mESC self-renewal in the absence of LIF (Ying et al., 2008Ying Q.-L. Wray J. Nichols J. Batlle-Morera L. Doble B. Woodgett J. Cohen P. Smith A. The ground state of embryonic stem cell self-renewal.Nature. 2008; 453: 519-523Crossref PubMed Scopus (2530) Google Scholar). Because the TGFβ/Activin A/Nodal signaling cascade is essential to maintain undifferentiated hESCs and EpiSCs, but dispensable for mESC self-renewal, we tested whether the addition of an inhibitor of the type 1 TGFβ receptor, ALK5 (A-83-01), could help stabilize our riPSC cultures.” In addition, we omitted to mention that while our study was under review, Silva et al., 2008Silva J. Barrandon O. Nichols J. Kawaguchi J. Theunissen T.W. Smith A. Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition.PLoS Biol. 2008; 6: 2237-2247https://doi.org/10.1371/journal.pbio.0060253Crossref Scopus (651) Google Scholar also published the use of these two inhibitors in the generation and propagation of mouse iPSCs. We apologize for any confusion caused. Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical InhibitorsLi et al.Cell Stem CellDecember 18, 2008In BriefConventional mouse and human embryonic stem cells (ESCs) can be typically derived by in vitro culture of blastocysts (Martin, 1981; Thomson et al., 1998), and induced pluripotent stem cells (iPSCs) can be generated by reprogramming somatic cells using defined genetic transduction methods (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007). In both cases, different signaling pathways appear to regulate pluripotency with different characteristics in the two species. However, while rat ESC-like cells have been established based on certain traits (Demers et al., 2007; Ruhnke et al., 2003; Schulze et al., 2006; Ueda et al., 2008), to date, these lines fall short of exhibiting true pluripotency (e.g., fail to form teratoma or no/little contribution to chimerism) and thus cannot be considered authentic rat ESCs. Full-Text PDF Open Archive

Pluripotent Stem Cells Derived From Mouse Primordial Germ Cells by Small Molecule Compounds

Isolation and Long Term Culture of Human Primordial Germ Cells

Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical Inhibitors

Brief Report: Combined Chemical Treatment Enables Oct4-Induced Reprogramming from Mouse Embryonic Fibroblasts

Conversion of Mouse Epiblast Stem Cells to an Earlier Pluripotency State by Small Molecules*

In vitro expansion of mouse primordial germ cell‐like cells recapitulates an epigenetic blank slate

Scalable and Efficient Generation of Mouse Primordial Germ Cell-like Cells

Generation of Human-Induced Pluripotent Stem Cells in the Absence of Exogenous Sox2

Human Germ Cell Differentiation from Fetal- and Adult-Derived Induced Pluripotent Stem Cells

Determining the potency of primordial germ cells by injection into early mouse embryos

Derivation of Pluripotent Stem Cells with In Vivo Embryonic and Extraembryonic Potency

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Germline Competency of Human Embryonic Stem Cells Depends on Eomesodermin †

Epidermal growth factor promotes proliferation of chicken germ cells (PGCs) and differentiation potency of embryoid bodies derived from PGCs

Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Oct4 and Klf4 with Small-Molecule Compounds

Reprogramming Primordial Germ Cells into Pluripotent Stem Cells

Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors

Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds

Mouse-induced pluripotent stem cells have the potential to differentiate into induced primordial germ cells]

Derivation of Intermediate Pluripotent Stem Cells Amenable to Primordial Germ Cell Specification

Pluripotent Stem Cells Induced from Mouse Neural Stem Cells and Small Intestinal Epithelial Cells by Small Molecule Compounds